Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Clinical trial NCT04725448 · UNKNOWN

Trial details

NCT number: NCT04725448
Sponsor: Sichuan Cancer Hospital and Research Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Sarcomatoid Carcinoma Non-small Cell Lung Cancer Lung Diseases Thoracic Neoplasms

Start date: 2021-04-06
Primary completion: 2022-03-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.